Global Self-Injections Market will be worth USD 79.5 billion by 2022 – New market reports by Data Bridge Market Research

“Global Self-Injections Market is expected to grow at 22.6% in the forecast period 2016 to 2022”
Global Self-Injections Market, By Product (Devices (Needle-Free Injectors, Auto Injectors, Pen Injectors, Wearable Injectors), Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), By Route Of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), By End-User, By Distribution Channel , By Geography – Trends and Forecast to 2022

Global Self-Injections Market is expected to reach USD 79.5 billion by 2022, from USD 19.1 billion in 2015 growing at a CAGR of 22.6% during the forecast period of 2016 to 2022.

Global Self-Injections Market is segmented based on product types, dosage form, therapeutic application, route of administration, end-user, distribution channel, and geography.

For Sample Report: http://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2022/

On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices. The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting formulations.

On the basis of dosage the self injections market is segmented into into single dose and multi dose.

Based on therapeutic application, the market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others.

To read more about the scope and findings of this report visit: http://databridgemarketresearch.com/self-injections-market-poised-grow-22-6/

On the basis of route of administration, the market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.

Based on end-user, the market is segmented into patient, physicians, home care settings and, others.

On the basis of distribution channel the market is segmented into hospital pharmacies, private clinics, chemist, and online pharmacies.

Based on geography, the market report covers data for regions namely North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.

Global players operating in this market are players operating in this market are Abbvie, Inc., Antares Pharma, 3M, Becton Dickinson & Company, Baxter International Inc., Penjet Corporation, PharmaJet, Gerresheimer AG, Pfizer Inc., Terumo Corporation, Mylan Specialty L.P., SHL Group, Bespak, Janssen Biotech, Inc., Insulet Corporation, Unilife Corporation, West Pharmaceutical Services, Inc., Ypsomed, among other companies.

To Browse Full Report and Pricing: http://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2022/

 

Table of Content:

1        INTRODUCTION

        1.1.      OVERVIEW OF THE  SELF-INJECTIONS MARKET

        1.2.      MARKET SEGMENTATION & COVERAGE

                   1.2.1. CURRENCY AND PRICING 

                   1.2.2. LIMITATION

                   1.2.3. STAKEHOLDERS

2        RESEARCH METHODOLOGY

        2.1.      KEY TAKEAWAYS

        2.2.      ARRIVING AT THE GLOBAL SELF-INJECTIONS MARKET

                   2.2.1. MARKET CRACKDOWN APPROACH 

                   2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

                   2.2.3. DATA TRIANGULATION

                   2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

                   2.2.5.  KEY DATA POINTS FROM SECONDARY SOURCES

                   2.2.6.  PORTER’S FIVE FORCES MATRIX

        2.4.      GLOBAL SELF-INJECTIONS MARKET: RESEARCH SNAPSHOT

        2.5.      ASSUMPTIONS

3        MARKET LANDSCAPE SUMMARY

4        PREMIUM INSIGHTS

        4.1.      OVERVIEW

        4.2.      GLOBAL SELF-INJECTIONS MARKET: KEY PRIMARY INSIGHTS

        4.3.      MARKET OVERVIEW

        4.4.      KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5        SELF-INJECTIONS MARKET, BY TYPE

       5.1.   OVERVIEW

       5.2.   DEVICES

       5.3. FORMULATIONS

6        SELF-INJECTIONS MARKET,  BY DOSAGE FORM

        6.1.     OVERVIEW

        6.2.      SINGLE DOSE

        6.3.      MULTI-DOSE

7 SELF-INJECTIONS MARKET,  BY THERAPEUTIC APPLICATION

        7.1.      OVERVIEW

        7.2.      AUTOIMMUNE DISEASES

        7.3.      HORMONAL DISORDERS

        7.4.      ONCOLOGY

        7.5.      ORPHAN DISEASES

        7.6.      PAIN MANAGEMENT

        7.7.        RESPIRATORY THERAPY

        7.8.        OTHERS

8 SELF-INJECTIONS MARKET, BY ROUTE OF ADMINISTRATION

        8.1.      OVERVIEW

        8.2.      SKIN

        8.3.      CIRCULATORY/MUSCULOSKELETAL

        8.4.      ORGANS

        8.5.      CENTRAL NERVOUS SYSTEM

9        SELF-INJECTIONS MARKET, BY END-USER

        9.1.      OVERVIEW

        9.2.      PATIENT

        9.3.      PHYSICIANS

        9.4.        HOME CARE SETTINGS

        9.5.         OTHERS

10      SELF-INJECTIONS MARKET, BY DISTRIBUTION CHANNEL

       10.1.   OVERVIEW

       10.2.   HOSPITAL PHARMACIES

       10.3.   PRIVATE CLINICS

       10.4.      CHEMIST

       10.5.     ONLINE PHARMACIES

11      SELF-INJECTIONS MARKET, BY GEOGRAPHY

       11.1.   COUNTRYWISE SELF-INJECTIONS MARKET,                             

                 (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

            11.1.1.      NORTH AMERICA

                          11.1.1.1.      U.S.

                          11.1.1.2.      CANADA

                          11.1.1.3.      MEXICO

            11.1.2.      EUROPE

                          11.1.2.1.      GERMANY

                          11.1.2.2.      FRANCE

                          11.1.2.3.      U.K.

                          11.1.2.4.      ITALY

                          11.1.2.5.      SPAIN

                          11.1.2.6.      RUSSIA

                          11.1.2.7.      TURKEY

                          11.1.2.8.      BELGIUM

                          11.1.2.9.      NETHERLANDS

                          11.1.2.10.    SWITZERLAND

                          11.1.2.11.    REST OF EUROPE

            11.1.3.      ASIA-PACIFIC (APAC)

                          11.1.3.1.      JAPAN

                          11.1.3.2.      CHINA

                          11.1.3.3.      SOUTH KOREA

                          11.1.3.4.      INDIA

                          11.1.3.5.      AUSTRALIA

                          11.1.3.6.      SINGAPORE

                          11.1.3.7.      THAILAND

                          11.1.3.8.      MALAYSIA

                          11.1.3.9.      INDONESIA

                          11.1.3.10.    PHILIPPINES

                          11.1.3.11.    REST OF APAC

            11.1.4.    LATIN AMERICA

            11.1.5.    MIDDLE EAST AND AFRICA

11.2.   KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

12      SELF-INJECTIONS MARKET: COMPETITIVE LANDSCAPE

12.1.   GLOBAL SELF-INJECTIONS MARKET: COMPANY SHARE ANALYSIS

12.2.   U.S. SELF-INJECTIONS MARKET: COMPANY SHARE ANALYSIS

12.3.   EUROPE SELF-INJECTIONS MARKET: COMPANY SHARE ANALYSIS

12.4.   ASIA-PACIFIC SELF-INJECTIONS MARKET: COMPANY SHARE ANALYSIS

12.5.   MERGERS & ACQUISITIONS

12.6.   NEW PRODUCT DEVELOPMENT & APPROVALS

12.7.   EXPANSIONS

12.8.   REGULATORY CHANGES

12.9.   PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

13      SELF-INJECTIONS MARKET, COMPANY PROFILES

13.1     BAXTER INTERNATIONAL INC.

                        13.1.1   OVERVIEW

                        13.1.2   SWOT ANALYSIS

                        13.1.3   PRODUCT PORTFOLIO

                        13.1.4   REVENUE ANALYSIS

                        13.1.5   ANALYSTS VIEW

13.2     BECTON DICKINSON & COMPANY

                         13.2.1   OVERVIEW

                         13.2.2   SWOT ANALYSIS

                         13.2.3   PRODUCT PORTFOLIO

                         13.2.4   REVENUE ANALYSIS

                         13.2.5   ANALYSTS VIEW

13.3    ANTARES PHARMA

                         13.3.1   OVERVIEW

                         13.3.2   SWOT ANALYSIS

                         13.3.3   PRODUCT PORTFOLIO

                         13.3.4   REVENUE ANALYSIS

                         13.3.5   ANALYST VIEW

13.4    ABBVIE, INC.

                         13.4.1   OVERVIEW

                         13.4.2   SWOT ANALYSIS

                         13.4.3   PRODUCT PORTFOLIO

                         13.4.4   REVENUE ANALYSIS

                         13.4.5   ANALYSTS VIEW

13.5    3M

                         13.5.1   OVERVIEW

                         13.5.2   SWOT ANALYSIS

                         13.5.3   PRODUCT PORTFOLIO

                         13.5.4   REVENUE ANALYSIS

                         13.5.5   ANALYSTS VIEW

13.6    PENJET CORPORATION

                         13.6.1   OVERVIEW

                         13.6.2   SWOT ANALYSIS

                         13.6.3   PRODUCT PORTFOLIO

                         13.6.4   REVENUE ANALYSIS

                         13.6.5   ANALYSTS VIEW

13.7    PHARMAJET

                         13.7.1   OVERVIEW

                         13.7.2   SWOT ANALYSIS

                         13.7.3   PRODUCT PORTFOLIO

                         13.7.4   REVENUE ANALYSIS

                         13.7.5   ANALYSTS VIEW

13.8      PFIZER INC.

                         13.8.1   OVERVIEW

                         13.8.2   SWOT ANALYSIS

                         13.8.3   PRODUCT PORTFOLIO

                         13.8.4   REVENUE ANALYSIS

                         13.8.5   ANALYSTS VIEW

13.9    TERUMO CORPORATION

                         13.9.1   OVERVIEW

                         13.9.2   SWOT ANALYSIS

                         13.9.3   PRODUCT PORTFOLIO

                         13.9.4   REVENUE ANALYSIS

                         13.9.5   ANALYSTS VIEW

13.10  MYLAN SPECIALTY L.P.

                         13.10.1   OVERVIEW

                         13.10.2   SWOT ANALYSIS

                         13.10.3   PRODUCT PORTFOLIO

                         13.10.4   REVENUE ANALYSIS

                         13.10.5   ANALYSTS VIEW

13.11  WEST PHARMACEUTICAL SERVICES, INC.

                         13.11.1   OVERVIEW

                         13.11.2   SWOT ANALYSIS

                         13.11.3   PRODUCT PORTFOLIO

                         13.11.4   REVENUE ANALYSIS

                         13.11.5   ANALYSTS VIEW

13.12  JANSSEN BIOTECH, INC.

                         13.12.1   OVERVIEW

                         13.12.2   SWOT ANALYSIS

                         13.12.3   PRODUCT PORTFOLIO

                         13.12.4   REVENUE ANALYSIS

                         13.12.5   ANALYSTS VIEW

13.13  INSULET CORPORATION

                         13.13.1   OVERVIEW

                         13.13.2   SWOT ANALYSIS

                         13.13.3   PRODUCT PORTFOLIO

                         13.13.4   REVENUE ANALYSIS

                         13.13.5   ANALYSTS VIEW

13.14  YPSOMED

                         13.14.1   OVERVIEW

                         13.14.2   SWOT ANALYSIS

                         13.14.3   PRODUCT PORTFOLIO

                         13.14.4   REVENUE ANALYSIS

                         13.14.5   ANALYSTS VIEW

13.15  BESPAK

                         13.15.1   OVERVIEW

                         13.15.2   SWOT ANALYSIS

                         13.15.3   PRODUCT PORTFOLIO

                         13.15.4   REVENUE ANALYSIS

                         13.15.5   ANALYSTS VIEW

13.16  SHL GROUP

                         13.16.1   OVERVIEW

                         13.16.2   SWOT ANALYSIS

                         13.16.3   PRODUCT PORTFOLIO

                         13.16.4   REVENUE ANALYSIS

                         13.16.5   ANALYSTS VIEW

13.17  GERRESHEIMER AG

                         13.17.1   OVERVIEW

                         13.17.2   SWOT ANALYSIS

                         13.17.3   PRODUCT PORTFOLIO

                         13.17.4   REVENUE ANALYSIS

                         13.17.5   ANALYSTS VIEW

13.18  HASELMEIER

                         13.18.1   OVERVIEW

                         13.18.2   SWOT ANALYSIS

                         13.18.3   PRODUCT PORTFOLIO

                         13.18.4   REVENUE ANALYSIS

                         13.18.5   ANALYSTS VIEW

13.19.   UNILIFE CORP.

                         13.19.1   OVERVIEW

                         13.19.2   SWOT ANALYSIS

                         13.19.3   PRODUCT PORTFOLIO

                         13.19.4   REVENUE ANALYSIS

                         13.19.5   ANALYSTS VIEW

14      APPENDIX

15      ABOUT DATA BRIDGE MARKET RESEARCH

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Related Reports:

Global Drug Delivery Devices Market – Trends and Forecast to 2022

By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022

Global Cord Stem Cell Banking Market – Trends and Forecast to 2022

By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2022/